Cadrenal Therapeutics, Inc. Common Stock Strategic Asset Allocation Index
Cadrenal Therapeutics, Inc. Common Stock strategic asset allocation index. Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a Strategic Asset Allocation Index of 1.1% as of June 2023. Strategic assets (PP&E of $36.10K plus long-term investments of $-) total $36.10K, measured against net assets of $3.18 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Cadrenal Therapeutics, Inc. Common Stock balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Cadrenal Therapeutics, Inc. Common Stock Strategic Asset Allocation Index by Year (None–None)
Cadrenal Therapeutics, Inc. Common Stock strategic asset allocation index by year from None to None. The table below presents the year-by-year Strategic Asset Allocation Index for Cadrenal Therapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CVKD market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|